Description

RHINOMUNE® is for vaccination of healthy horses 3 months of age or older as an aid in preventing respiratory disease caused by equine herpesvirus type 1 (EHV-1). RHINOMUNE is prepared by growing an attenuated strain of EHV-1 on an equine cell line and is packaged in freeze-dried form. The sterile diluent is used to rehydrate the freeze-dried component.

Approved Uses

Vaccination of healthy horses 3 months of age or older as an aid in prevention of respiratory disease caused by equine herpesvirus (EHV-1).

Key Features

- Helps prevent respiratory disease caused by equine herpesvirus 1 (EHV-1)

- Modified-live EHV-1 component triggers a more effective immune response than killed vaccines

- Safe in pregnant mares

- Convenient, small-volume dose (1 mL)

- Low incidence of injection-site reactions such as swelling or stiffness

Packaging

Available in single-dose packets with syringes, and 1- and 5-dose vials.